Calidi Biotherapeutics, Inc. (CLDI)
Stock-Based Compensation
$1.37M
TTM · Period ending: · USD
CLDI Stock-Based Compensation
Latest reported$1.37Mperiod ending
Latest reported$1.37Mperiod ending
CLDI Stock-Based Comp ($968.00K → $1.37M)
Annual stock-based compensation
High-resolution chart · PNG
CLDI stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,108,000 | |
| 2,957,000 | |
| 4,809,000 | |
| 6,143,000 | |
| 1,327,000 | |
| 968,000 |